These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14595352)

  • 21. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
    Burkhart CG
    J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
    [No Abstract]   [Full Text] [Related]  

  • 22. European Directive on the Legal Protection of Biotechnological Inventions: scope, status and controversies in a nutshell.
    Hakki MM
    E Law; 2004 Mar; 11(1):E4. PubMed ID: 16903025
    [No Abstract]   [Full Text] [Related]  

  • 23. Color coding of multisource products should be standardized or eliminated.
    Clifton GD; Record KE
    Am J Hosp Pharm; 1988 May; 45(5):1066. PubMed ID: 3400647
    [No Abstract]   [Full Text] [Related]  

  • 24. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology.
    Jenkinson DH; Barnard EA; Hoyer D; Humphrey PP; Leff P; Shankley NP
    Pharmacol Rev; 1995 Jun; 47(2):255-66. PubMed ID: 7568328
    [No Abstract]   [Full Text] [Related]  

  • 25. Biotech's defining moments.
    Miller HI
    Trends Biotechnol; 2007 Feb; 25(2):56-9. PubMed ID: 17173993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents?
    Antman EM; Ferguson JJ
    Circulation; 2003 Nov; 108(21):2604-7. PubMed ID: 14638523
    [No Abstract]   [Full Text] [Related]  

  • 27. Paediatric clinical trials: redressing the imbalance.
    Schreiner MS
    Nat Rev Drug Discov; 2003 Dec; 2(12):949-61. PubMed ID: 14654794
    [No Abstract]   [Full Text] [Related]  

  • 28. New technology ethic.
    Macer D
    Taiwan Yi Xue Ren Wen Xue Kan; 2001 Oct; 2(1-2):41-7. PubMed ID: 15011655
    [No Abstract]   [Full Text] [Related]  

  • 29. [New EU law--an improvement for Norwegian children?].
    Kalikstad B
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1770-2. PubMed ID: 19756062
    [No Abstract]   [Full Text] [Related]  

  • 30. [ATC classification: lights and shadows].
    Bosone E; Secondi A
    Boll Chim Farm; 1990 Apr; 129(4):169-72. PubMed ID: 2245006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current standards in reported drug trials.
    Reiffenstein RJ; Schiltroth AJ; Todd DM
    Can Med Assoc J; 1968 Dec; 99(23):1134-5. PubMed ID: 4881692
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medical questions with respect to the introduction of new drug specialties into the German Federal Republic].
    Grillmaier JB
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):315-31. PubMed ID: 5365590
    [No Abstract]   [Full Text] [Related]  

  • 33. Action needed to harmonize regulation of low-level presence of biotech traits.
    Krueger R; Le Buanec B
    Nat Biotechnol; 2008 Feb; 26(2):161-2. PubMed ID: 18259165
    [No Abstract]   [Full Text] [Related]  

  • 34. EU to monitor for Chinese GM rice.
    Huggett B
    Nat Biotechnol; 2008 May; 26(5):478. PubMed ID: 18464757
    [No Abstract]   [Full Text] [Related]  

  • 35. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 36. Inherited wealth.
    Wyke A
    Economist; 1988 Apr; 307():3-18. PubMed ID: 17256228
    [No Abstract]   [Full Text] [Related]  

  • 37. Orphans at the window.
    Nat Biotechnol; 2004 Sep; 22(9):1055. PubMed ID: 15340451
    [No Abstract]   [Full Text] [Related]  

  • 38. No Munich on GM crops.
    Malvoisin P; Grausz JD
    Nat Biotechnol; 2004 Dec; 22(12):1501; discussion 1501. PubMed ID: 15583648
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene therapy legislation in The Netherlands.
    Bleijs DA; Haenen IT; Bergmans JE
    J Gene Med; 2007 Oct; 9(10):904-9. PubMed ID: 17721872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Food, health claims and drugs. Introduction: why such a session devoted to this topic].
    Bourlioux P
    Ann Pharm Fr; 2008; 66(5-6):e1-3. PubMed ID: 19061722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.